December 5, 2016 H3 Biomedicine Announces Data from Lead Development Program of H3B-8800 in Pre-Clinical Models of Hematologic Cancers Data Presented at American Society of Hematology Meeting Supports Initiation of Phase 1 Clinical Trials in Patients with Spliceosome Mutant… Read More